Interestingly, PD-L1+/CD63+ EVs were detected in all DLBCL patients, as opposed to cellular PD-L1 expression, which is only detected in about 20% of patients with DLBCL disease. The gene discussed is CD274; the disease is diffuse large B-cell lymphoma.